Why Are Investors Re-Evaluating Large Pharmaceutical Companies? | VanEck Chile
Pharmaceutical companies are navigating a changing landscape defined by GLP-1 innovation, AI -supported drug discovery, and evolving healthcare ...
- Topics
- HealthcareMarkets & Investment
- Tracked via
- “AI Risks”